Cargando…
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression
TP53 is one of the most frequently altered genes in prostate cancer. The precise assessment of its focal alterations in primary tumors by immunohistochemistry (IHC) has significantly enhanced its prognosis. p53 protein expression and lymphovascular invasion (LVI) were evaluated for predicting metast...
Autores principales: | Gesztes, William, Schafer, Cara, Young, Denise, Fox, Jesse, Jiang, Jiji, Chen, Yongmei, Kuo, Huai-Ching, Mwamukonda, Kuwong B., Dobi, Albert, Burke, Allen P., Moul, Judd W., McLeod, David G., Rosner, Inger L., Petrovics, Gyorgy, Tan, Shyh-Han, Cullen, Jennifer, Srivastava, Shiv, Sesterhenn, Isabell A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967869/ https://www.ncbi.nlm.nih.gov/pubmed/35354846 http://dx.doi.org/10.1038/s41598-022-08826-5 |
Ejemplares similares
-
Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009) -
Prostate cancer marker panel with single cell sensitivity in urine
por: Nickens, Kristen P., et al.
Publicado: (2015) -
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
por: Rastogi, Anshu, et al.
Publicado: (2016) -
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence
por: Yan, Wusheng, et al.
Publicado: (2019) -
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)